金迪克

688670 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

2.1B ($310.5M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

80.8M

Net Income

-93.5M

Gross Margin

N/A

Op. Margin

-141.1%

Net Margin

-115.7%

ROE

-7.3%

ROA

-6.1%

D/E

0.20

Dividend Yield

N/A

EPS

-0.76

Current Ratio

2.76

Price History

Company Info

Industry	C27医药制造业
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 金迪克

Ticker	688670
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业